2008
DOI: 10.1016/s1877-184x(09)70037-1
|View full text |Cite
|
Sign up to set email alerts
|

Chapter 7 Inflammatory Optic Neuropathies Not Associated with Multiple Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 162 publications
0
10
0
Order By: Relevance
“…Colour vision is frequently impaired and, like IDON, there are many possible different patterns of visual field loss. Over 50% have optic disc pallor at presentation, but several other abnormalities are common including disc swelling, periphlebitis and granuloma; only 10% have truly normal fundi 29 31 32…”
Section: Mimicsmentioning
confidence: 99%
See 3 more Smart Citations
“…Colour vision is frequently impaired and, like IDON, there are many possible different patterns of visual field loss. Over 50% have optic disc pallor at presentation, but several other abnormalities are common including disc swelling, periphlebitis and granuloma; only 10% have truly normal fundi 29 31 32…”
Section: Mimicsmentioning
confidence: 99%
“…Relapses are usually corticosteroid-sensitive, but they continue to recur so patients end up on low-dose maintenance therapy 33. The final visual acuity is, overall, worse than that of IDON, and there is a strong suggestion that earlier, more aggressive treatment with corticosteroids gives a better outcome 32 34…”
Section: Mimicsmentioning
confidence: 99%
See 2 more Smart Citations
“…The primary objective of the trial was the assessment of the efficacy of corticosteroids in the treatment of optic neuritis. It also gives some information about the clinical profile of optic neuritis, its natural history and its relationship to MS 3 . Inclusion criteria in ONTT included a clinical syndrome consistent with unilateral optic neuritis (including a relative afferent pupillary defect and a visual field defect in the affected eye), visual symptoms of eight days or less, no previous episodes of optic neuritis in the affected eye, no previous corticosteroid treatment for optic neuritis or MS, and no evidence of a systemic disease other than MS as a cause for the optic neuritis 4 .…”
Section: Optic Neuritis Treatment Trial (Ontt)mentioning
confidence: 99%